Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong
· Delayed Price · Currency is HKD 12.36
+0.72 (6.19%)
May 13, 2025, 4:08 PM HKT
Medlive Technology Market Cap
Medlive Technology has a market cap or net worth of 9.06 billion as of May 13, 2025. Its market cap has increased by 69.30% in one year.
Market Cap
9.06B
Enterprise Value
4.72B
Revenue
594.29M
Ranking
n/a
PE Ratio
27.14
Stock Price
12.36
Market Cap Chart
Since July 15, 2021, Medlive Technology's market cap has decreased from 21.40B to 9.06B, a decrease of -57.66%. That is a compound annual growth rate of -20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 9.06B | 24.60% |
| Dec 31, 2024 | 7.27B | 17.93% |
| Dec 29, 2023 | 6.16B | 0.75% |
| Dec 30, 2022 | 6.12B | -68.46% |
| Dec 31, 2021 | 19.40B | -9.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 196.39B |
| Hansoh Pharmaceutical Group Company | 130.51B |
| JD Health International | 121.51B |
| WuXi Biologics | 94.03B |
| Alibaba Health Information Technology | 84.76B |
| Innovent Biologics | 82.48B |
| Akeso | 72.61B |
| Sichuan Kelun-Biotech Biopharmaceutical | 70.13B |